EISAI PHARMACEUTICALS INDIA PVT LTD

EISAI PHARMACEUTICALS INDIA PVT LTD is primarily a trading and distribution company.

Company Introduction:

EISAI PHARMACEUTICALS INDIA PVT LTD is the Indian subsidiary of Eisai Co., Ltd., a global research and development-based pharmaceutical company headquartered in Japan. The Indian entity's main function is the sales, marketing, and distribution of Eisai's innovative pharmaceutical products throughout India. These products are developed to address unmet medical needs, particularly in therapeutic areas such as neurology and oncology. While the parent company, Eisai Co., Ltd., is a major manufacturer of pharmaceuticals globally, EISAI PHARMACEUTICALS INDIA PVT LTD serves as its commercial and operational arm in the Indian market, facilitating patient access to Eisai's medicines. The company operates with a commitment to Eisai's human health care (hhc) philosophy, aiming to provide significant benefits to patients and their families.

EISAI PHARMACEUTICALS INDIA PVT LTD manufactures or sells products primarily in the therapeutic areas of Oncology and Neurology. Their key products include:

Lenvima (Lenvatinib) for various cancers including hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid cancer.

Halaven (Eribulin) for metastatic breast cancer and liposarcoma.

Fycompa (Perampanel) for epilepsy.

Aricept (Donepezil) for Alzheimer's disease.

Pariet (Rabeprazole) for acid-related disorders.

Methycobal (Methylcobalamin) for peripheral neuropathy.